{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:09Z","timestamp":1772166309431,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Mycoplasma<\/jats:italic>\n                    pneumoniae pneumonia (MPP) is a common type of pneumonia among school-aged children and adolescents. Jinzhen Oral Liquid (JZOL) and Azithromycin (AZ) are commonly used treatments in traditional Chinese medicine (TCM) and Western medicine, respectively. There are several clinical and basic research reports on their solo effect against MPP, enabling their combined treatment to become possible. However, the mechanisms and specific pharmacodynamics of their combined therapy remain unclear. In this study, we conducted a mechanistic analysis of the combination of JZOL and AZ based on network target, elucidating their modular network regulatory mechanisms. The modular mechanisms involve four modules, including hormone response, cell differentiation and migration, signal transduction, oxygen and hypoxia response, centered by TNF signaling pathway-mediated regulation. Under the instruction of computational analysis, we conducted a randomized, double-blind, three-armed, parallel-controlled, multicenter clinical study of different doses of JZOL combined with AZ for the treatment of MPP in children. The objective of clinical research is to evaluate the synergistic effect of different doses of JZOL combined with AZ in the treatment of children with MPP, shortening the course of disease and improving prognosis, while observing the safety of clinical application. At the study endpoint, the median time to clinical recovery showed statistically significant differences (The double-dose group lasts for 5\u00a0days, the regular-dose group lasts for 6\u00a0days, and the placebo group lasts for 8\u00a0days), which were also observed between groups for time to complete fever remission, time to relief of cough\/phlegm, effective rate of chest X-ray improvement, and rate of healing of TCM symptoms. Different doses of JZOL combined with AZ have shown the effects of shortening the course of the disease, relieving the symptoms, and improving the prognosis. The research program composed of computational prediction and clinical trials can significantly accelerate the research and development process and identify more effective treatment with good safety, which is worthy of clinical promotion. Chinese Clinical Trial Registry ChiCTR1800019007\n                  <\/jats:p>","DOI":"10.1186\/s13020-025-01149-3","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T06:57:45Z","timestamp":1751353065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A computational-based new treatment strategy with three-armed RCT on Mycoplasma pneumoniae pneumonia in children"],"prefix":"10.1186","volume":"20","clinical-trial-number":[{"clinical-trial-number":"chictr1800019007","registry":"10.18810\/chictr"}],"author":[{"given":"Chengliang","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengxuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weibo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongsong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"17","key":"1149_CR1","first-page":"1304","volume":"30","author":"Z Chen","year":"2015","unstructured":"Chen Z, Shang Y, Zhao S. Expert consensus on the diagnosis and treatment of mycoplasma pneumoniae pneumonia in children (2015 edition). Chin J Pr Pediatr. 2015;30(17):1304\u20138.","journal-title":"Chin J Pr Pediatr"},{"issue":"9","key":"1149_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372(9):835\u201345.","journal-title":"N Engl J Med"},{"issue":"5","key":"1149_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096674","volume":"9","author":"WK Liu","year":"2014","unstructured":"Liu WK, et al. Epidemiology of acute respiratory infections in children in Guangzhou: a three-year study. PLoS ONE. 2014;9(5): e96674.","journal-title":"PLoS ONE"},{"key":"1149_CR4","unstructured":"Zhao, S., et al., Diagnosis and treatment guidelines for mycoplasma pneumoniae pneumonia in children (2023 Edition). Infectious Disease Information, 2023."},{"issue":"11","key":"1149_CR5","first-page":"1175","volume":"42","author":"H Yan","year":"2023","unstructured":"Yan H, Jing H, Hui-min Y. Integrated traditional Chinese and western medicine diagnosis and treatment scheme for mycoplasma pneumonia in children (2023 edition). Beijing J Tradit Chin Med. 2023;42(11):1175\u20139.","journal-title":"Beijing J Tradit Chin Med"},{"issue":"18","key":"1149_CR6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301775120","volume":"120","author":"H Xu","year":"2023","unstructured":"Xu H, et al. Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19. Proc Natl Acad Sci. 2023;120(18): e2301775120.","journal-title":"Proc Natl Acad Sci"},{"issue":"03","key":"1149_CR7","first-page":"499","volume":"38","author":"B Jie","year":"2023","unstructured":"Jie B, et al. Effect and mechanism of Jinzhen Oral Liquid on influenza virus pneumonia in mice. Drugs Clin. 2023;38(03):499\u2013504.","journal-title":"Drugs Clin"},{"issue":"01","key":"1149_CR8","first-page":"46","volume":"20","author":"Z Jingsheng","year":"2023","unstructured":"Jingsheng Z, et al. Pharmacological effects of Jinzhen oral liquid against viral pneumonia in mice infected with influenza H1N1\/FM1 and parainfluenza virus. Chin J Pharmacovigil. 2023;20(01):46\u201351+95.","journal-title":"Chin J Pharmacovigil"},{"issue":"17","key":"1149_CR9","first-page":"4707","volume":"47","author":"X Shu-juan","year":"2022","unstructured":"Shu-juan X, et al. Effect of Jinzhen oral liquid on cough after lipopolysaccharide-induced infection in rats and mechanism. China J Chin Mater Med. 2022;47(17):4707\u201314.","journal-title":"China J Chin Mater Med"},{"issue":"02","key":"1149_CR10","first-page":"1","volume":"27","author":"H Qian","year":"2021","unstructured":"Qian H, et al. Animal experimental study on antipyretic mechanism of Jinzhen oral liquid. J Pediatr Pharm. 2021;27(02):1\u20134.","journal-title":"J Pediatr Pharm"},{"issue":"09","key":"1149_CR11","first-page":"1959","volume":"15","author":"L Sujun","year":"2013","unstructured":"Sujun L, et al. Experimental study of Jinzhen Koufuye on acute lung injury induced by lipopolysaccharide in rats. Moder Tradit Chin Med Mater Med World Sc Technol. 2013;15(09):1959\u201365.","journal-title":"Moder Tradit Chin Med Mater Med World Sc Technol"},{"key":"1149_CR12","first-page":"1454","volume":"8","author":"A Hou","year":"2009","unstructured":"Hou A, et al. Experimental study on the inhibition of respiratory syncytial virus, SARS virus, and Mycoplasma pneumoniae by Jinzhen Oral Liquid in vitro. Chin J Prim. 2009;8:1454\u20135.","journal-title":"Chin J Prim"},{"key":"1149_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153874","volume":"95","author":"Q Ma","year":"2022","unstructured":"Ma Q, et al. Effect of Jinzhen granule on two coronaviruses: the novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action. Phytomedicine. 2022;95: 153874.","journal-title":"Phytomedicine"},{"issue":"17","key":"1149_CR14","first-page":"39","volume":"33","author":"D Benqi","year":"2023","unstructured":"Benqi D, et al. Clinical effect of Jinzhen oral liquid combined with azithromycin in treating children with Mycoplasma pneumoniae pneumonia (non-severe). Shenzhen J Integr Tradit Chin West Med. 2023;33(17):39\u201341.","journal-title":"Shenzhen J Integr Tradit Chin West Med"},{"issue":"15","key":"1149_CR15","first-page":"96","volume":"32","author":"G Xiquan","year":"2023","unstructured":"Xiquan G, et al. Clinical observation of Jinzhen oral liquid combined with interferon nebulization inhalation in the treatment of children with refractory Mycoplasma pneumonia. China Pharmac. 2023;32(15):96\u20139.","journal-title":"China Pharmac"},{"issue":"04","key":"1149_CR16","first-page":"38","volume":"25","author":"X Bingxin","year":"2019","unstructured":"Bingxin X, et al. Azithromycin combined with Jinzhen oral liquid in the treatment of children with Mycoplasma pneumonia pneumonia. J Pediatr Pharm. 2019;25(04):38\u201340.","journal-title":"J Pediatr Pharm"},{"key":"1149_CR17","first-page":"561","volume":"08","author":"Z Yuan","year":"2008","unstructured":"Yuan Z, et al. Diagnosis and treatment of Mycoplasma Pneumoniae Pneumonia. Chin J Pr Pediatr. 2008;08:561\u201372.","journal-title":"Chin J Pr Pediatr"},{"issue":"1","key":"1149_CR18","doi-asserted-by":"publisher","first-page":"bbad518","DOI":"10.1093\/bib\/bbad518","volume":"25","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine. Brief Bioinform. 2024;25(1):bbad518.","journal-title":"Brief Bioinform"},{"issue":"6262","key":"1149_CR19","first-page":"S72","volume":"350","author":"S Li","year":"2015","unstructured":"Li S. Mapping ancient remedies: applying a network approach to traditional Chinese medicine. Science. 2015;350(6262):S72\u20134.","journal-title":"Science"},{"key":"1149_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101144","author":"B Wang","year":"2024","unstructured":"Wang B, et al. Elucidating the role of artificial intelligence in drug development from the perspective of drug-target interactions. J Pharmac Anal. 2024. https:\/\/doi.org\/10.1016\/j.jpha.2024.101144.","journal-title":"J Pharmac Anal"},{"issue":"1","key":"1149_CR21","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1038\/s41467-018-06537-y","volume":"9","author":"H-H Qiao","year":"2018","unstructured":"Qiao H-H, et al. An efficient and multiple target transgenic RNAi technique with low toxicity in Drosophila. Nat Commun. 2018;9(1):4160.","journal-title":"Nat Commun"},{"key":"1149_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-S1-S32","volume":"11","author":"Y Huang","year":"2010","unstructured":"Huang Y, Li S. Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network. BMC Bioinform. 2010;11:1\u20139.","journal-title":"BMC Bioinform"},{"key":"1149_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409130","author":"Q Liu","year":"2025","unstructured":"Liu Q, et al. Leveraging network target theory for efficient prediction of drug-disease interactions: a transfer learning approach. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202409130.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"1149_CR24","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1016\/j.apsb.2024.09.001","volume":"14","author":"Q Fan","year":"2024","unstructured":"Fan Q, et al. Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: a multicenter, non-inferiority, prospective, randomized controlled trial. Acta Pharmac Sin B. 2024;14(12):5186\u2013200.","journal-title":"Acta Pharmac Sin B"},{"issue":"1","key":"1149_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13020-023-00781-1","volume":"18","author":"B Wang","year":"2023","unstructured":"Wang B, et al. Uncovering the mechanisms of Yi Qi Tong Qiao Pill in the treatment of allergic rhinitis based on network target analysis. Chin Med. 2023;18(1):88.","journal-title":"Chin Med"},{"issue":"7","key":"1149_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011764","volume":"5","author":"S Zhao","year":"2010","unstructured":"Zhao S, Li S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE. 2010;5(7): e11764.","journal-title":"PLoS ONE"},{"issue":"5","key":"1149_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1039\/C3MB70507B","volume":"10","author":"X Liang","year":"2014","unstructured":"Liang X, Li H, Li S. A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. Mol BioSyst. 2014;10(5):1014\u201322.","journal-title":"Mol BioSyst"},{"issue":"8","key":"1149_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/s42255-021-00437-0","volume":"3","author":"H Pang","year":"2021","unstructured":"Pang H, et al. Aberrant NAD+ metabolism underlies Zika virus\u2013induced microcephaly. Nat Metab. 2021;3(8):1109\u201324.","journal-title":"Nat Metab"},{"key":"1149_CR29","doi-asserted-by":"publisher","first-page":"738431","DOI":"10.3389\/fimmu.2021.738431","volume":"12","author":"EI Ramos","year":"2021","unstructured":"Ramos EI, et al. Mycoplasma genitalium and M. pneumoniae regulate a distinct set of protein-coding genes in epithelial cells. Front Immunol. 2021;12:738431.","journal-title":"Front Immunol"},{"key":"1149_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad027","author":"S Tian","year":"2023","unstructured":"Tian S, et al. Exploring pharmacological active ingredients of traditional Chinese medicine by pharmacotranscriptomic map in ITCM. Brief Bioinform. 2023. https:\/\/doi.org\/10.1093\/bib\/bbad027.","journal-title":"Brief Bioinform"},{"issue":"1","key":"1149_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-021-00475-w","volume":"6","author":"L Qiao","year":"2021","unstructured":"Qiao L, et al. Evaluation of the immunomodulatory effects of anti-COVID-19 TCM formulae by multiple virus-related pathways. Signal Transduct Target Ther. 2021;6(1):50.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1149_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12879-021-06508-7","volume":"21","author":"JG Ahn","year":"2021","unstructured":"Ahn JG, et al. Efficacy of tetracyclines and fluoroquinolones for the treatment of macrolide-refractory Mycoplasma pneumoniae pneumonia in children: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):1003.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1149_CR33","first-page":"2153","volume":"43","author":"L Yu-jun","year":"2018","unstructured":"Yu-jun L, et al. Efficacy and safety of Xiyanping injection combined with azithromycin in treating mycoplasma pneumonia of children: meta-analysis. China J Chin Mater Med. 2018;43(10):2153\u201361.","journal-title":"China J Chin Mater Med"},{"key":"1149_CR34","volume-title":"Zhu futang practical pediatrics","author":"Y Hu","year":"2015","unstructured":"Hu Y, et al. Zhu futang practical pediatrics. Beijing: People\u2019s Medical Publishing House; 2015."},{"key":"1149_CR35","volume-title":"Guidelines for the diagnosis and treatment of common diseases of pediatrics in traditional Chinese medicine","author":"China Association of Chinese Medicine","year":"2012","unstructured":"China Association of Chinese Medicine. Pneumonia with wheezing. In: Guidelines for the diagnosis and treatment of common diseases of pediatrics in traditional Chinese medicine. Beijing: China Traditional Chinese Medicine Press; 2012."},{"issue":"10","key":"1149_CR36","first-page":"745","volume":"51","author":"The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association","year":"2013","unstructured":"The Subspecialty Group of Respiratory Diseases, The Society of Pediatrics, Chinese Medical Association, The Editorial Board, Chinese Journal of Pediatrics. Guidelines for management of community acquired pneumonia in children (the revised edition of 2013)(I). Chin J Pediatr. 2013;51(10);745\u201352.","journal-title":"Chin J Pediatr"},{"key":"1149_CR37","unstructured":"General Office of the National Health and Family Planning Commission, Office of the National Administration of Traditional Chinese Medicine, Bureau of Drugs and Medical Devices, Health Department of the General Logistics Department, People\u2019s Liberation Army. Guiding principles for clinical use of antibiotic (version 2015); 2015. http:\/\/www.nhc.gov.cn."},{"issue":"12","key":"1149_CR38","first-page":"915","volume":"50","author":"JR Liu","year":"2012","unstructured":"Liu JR, et al. Clinical characteristics and predictive factors of refractory Mycoplasma pneumoniae pneumonia. Zhonghua Er Ke Za Zhi. 2012;50(12):915\u20138.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"3","key":"1149_CR39","first-page":"172","volume":"52","author":"L Chen","year":"2014","unstructured":"Chen L, et al. Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children. Zhonghua Er Ke Za Zhi. 2014;52(3):172\u20136.","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"1149_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8050726","author":"EA Yang","year":"2019","unstructured":"Yang EA, et al. Early corticosteroid therapy for Mycoplasma pneumoniae Pneumonia irrespective of used antibiotics in Children. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8050726.","journal-title":"J Clin Med"},{"issue":"3","key":"1149_CR41","doi-asserted-by":"publisher","first-page":"e12810","DOI":"10.1111\/cmi.12810","volume":"20","author":"OA Prince","year":"2018","unstructured":"Prince OA, et al. Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium. Cell Microbiol. 2018;20(3):e12810.","journal-title":"Cell Microbiol"},{"issue":"1","key":"1149_CR42","doi-asserted-by":"publisher","first-page":"L220","DOI":"10.1152\/ajplung.90204.2008","volume":"295","author":"K Chmura","year":"2008","unstructured":"Chmura K, et al. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L220\u201330.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"1149_CR43","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.4049\/jimmunol.1100573","volume":"188","author":"Y Wang","year":"2012","unstructured":"Wang Y, et al. SHP-1 as a critical regulator of Mycoplasma pneumoniae-induced inflammation in human asthmatic airway epithelial cells. J Immunol. 2012;188(7):3371\u201381.","journal-title":"J Immunol"},{"issue":"15","key":"1149_CR44","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1016\/j.molimm.2008.06.012","volume":"45","author":"J Liu","year":"2008","unstructured":"Liu J, Yoshida Y, Yamashita U. DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase. Mol Immunol. 2008;45(15):3984\u20139.","journal-title":"Mol Immunol"},{"issue":"7","key":"1149_CR45","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1128\/MCB.19.7.4798","volume":"19","author":"N Sizemore","year":"1999","unstructured":"Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65\/RelA subunit. Mol Cell Biol. 1999;19(7):4798\u2013805.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1149_CR46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jaci.2012.03.002","volume":"130","author":"BJ Hsia","year":"2012","unstructured":"Hsia BJ, et al. Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-\/- mice. J Allergy Clin Immunol. 2012;130(1):205-14.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1149_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3349\/ymj.2010.51.6.797","volume":"51","author":"S Reuter","year":"2010","unstructured":"Reuter S, Stassen M, Taube C. Mast cells in allergic asthma and beyond. Yonsei Med J. 2010;51(6):797\u2013807.","journal-title":"Yonsei Med J"},{"issue":"06","key":"1149_CR48","first-page":"883","volume":"29","author":"Z Yan-qiong","year":"2015","unstructured":"Yan-qiong Z, Shao L. Progress in network pharmacology for modern research of traditional Chinese medicine. Chin J Pharmacol Toxicol. 2015;29(06):883\u201392.","journal-title":"Chin J Pharmacol Toxicol"},{"issue":"06","key":"1149_CR49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1142\/S0192415X06004417","volume":"34","author":"S Li","year":"2006","unstructured":"Li S, et al. Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS. Am J Chin Med. 2006;34(06):937\u201347.","journal-title":"Am J Chin Med"},{"key":"1149_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-16-0753-0","volume-title":"\u201cNetwork target\u201d theory and network pharmacology","author":"S Li","year":"2021","unstructured":"Li S, Ding Q, Wang X. \u201cNetwork target\u201d theory and network pharmacology. Cham: Springer; 2021. p. 1\u201334."},{"issue":"2","key":"1149_CR51","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11(2):110\u201320.","journal-title":"Chin J Nat Med"},{"issue":"1","key":"1149_CR52","first-page":"7","volume":"47","author":"ZY Wang","year":"2022","unstructured":"Wang ZY, et al. Traditional Chinese medicine network pharmacology: development in new era under guidance of network pharmacology evaluation method guidance. Zhongguo Zhong Yao Za Zhi. 2022;47(1):7\u201317.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1149_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","volume":"29","author":"M Wang","year":"2014","unstructured":"Wang M, et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. Int J Infect Dis. 2014;29:18\u201323.","journal-title":"Int J Infect Dis"},{"key":"1149_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28207077","author":"N Ding","year":"2023","unstructured":"Ding N, et al. Total flavonoids from Camellia oleifera alleviated Mycoplasma pneumoniae-induced lung injury via inhibition of the TLR2-Mediated NF-\u03baB and MAPK pathways. Molecules. 2023. https:\/\/doi.org\/10.3390\/molecules28207077.","journal-title":"Molecules"},{"key":"1149_CR55","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20190190","author":"C Chen","year":"2019","unstructured":"Chen C, et al. Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt\/\u03b2-catenin and NF-\u03baB signaling. 2019. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20190190."},{"issue":"1","key":"1149_CR56","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s12879-020-05270-6","volume":"20","author":"Y Ling","year":"2020","unstructured":"Ling Y, et al. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infect Dis. 2020;20(1):534.","journal-title":"BMC Infect Dis"},{"issue":"Pt 12","key":"1149_CR57","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1099\/jmm.0.47119-0","volume":"56","author":"N Miyashita","year":"2007","unstructured":"Miyashita N, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007;56(Pt 12):1625\u20139.","journal-title":"J Med Microbiol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01149-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01149-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:05:28Z","timestamp":1751353528000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01149-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1149"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01149-3","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20190190","asserted-by":"subject"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4989483\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state no competing interests or financial support influenced the outcome of this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}